title: Does HCV infection have a more favourable outcome in Tanzanian people? Data from the Lugalawa study.
authors.forename: M
authors.initials: M
authors.lastname: Puato
authors.forename: I
authors.initials: I
authors.lastname: Migliorato
authors.forename: C
authors.initials: C
authors.lastname: Tirrito
authors.forename: M
authors.initials: M
authors.lastname: Ruvoletto
authors.forename: M
authors.initials: M
authors.lastname: Zanardo
authors.forename: P
authors.initials: P
authors.lastname: Pauletto
authors.forename: P
authors.initials: P
authors.lastname: Pontisso
mesh_terms: D000293:Adolescent; D000328:Adult; D003430:Cross-Sectional Studies; D016174:Hepacivirus / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000453:epidemiology*; D006801:Humans; D008099:Liver / Q000503:physiopathology; D008875:Middle Aged; D011379:Prognosis; D012367:RNA, Viral / Q000097:blood*; D012424:Rural Population / Q000706:statistics & numerical data; D016036:Seroepidemiologic Studies; D012698:Serologic Tests; D013636:Tanzania / Q000453:epidemiology
chemical_list: D012367:RNA, Viral